Your browser doesn't support javascript.
loading
Clinical Outcome of ALK-Positive Non-Small Cell Lung Cancer (NSCLC) Patients with De Novo EGFR or KRAS Co-Mutations Receiving Tyrosine Kinase Inhibitors (TKIs).
Schmid, Sabine; Gautschi, Oliver; Rothschild, Sacha; Mark, Michael; Froesch, Patrizia; Klingbiel, Dirk; Reichegger, Hermann; Jochum, Wolfram; Diebold, Joachim; Früh, Martin.
Affiliation
  • Schmid S; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland. Electronic address: sabine.schmid@kssg.ch.
  • Gautschi O; Department of Oncology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Rothschild S; Department of Oncology, University Hospital Basel, Basel, Switzerland.
  • Mark M; Department of Oncology, Cantonal Hospital Grisons, Chur, Switzerland.
  • Froesch P; Oncology Institute of Southern Switzerland, Regional Hospital San Giovanni, Bellinzona, Switzerland.
  • Klingbiel D; Swiss Group for Clinical Cancer Research, Berne, Switzerland.
  • Reichegger H; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Jochum W; Institute of Pathology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
  • Diebold J; Institute of Pathology, Cantonal Hospital Lucerne, Lucerne, Switzerland.
  • Früh M; Department of Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
J Thorac Oncol ; 12(4): 681-688, 2017 04.
Article in En | MEDLINE | ID: mdl-28007627
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Protein Kinase Inhibitors / ErbB Receptors / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: J Thorac Oncol Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins p21(ras) / Receptor Protein-Tyrosine Kinases / Carcinoma, Non-Small-Cell Lung / Drug Resistance, Neoplasm / Protein Kinase Inhibitors / ErbB Receptors / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged80 Language: En Journal: J Thorac Oncol Year: 2017 Type: Article